SK281857B6 - Dihydrobenzofurány, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie - Google Patents
Dihydrobenzofurány, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie Download PDFInfo
- Publication number
- SK281857B6 SK281857B6 SK2-97A SK297A SK281857B6 SK 281857 B6 SK281857 B6 SK 281857B6 SK 297 A SK297 A SK 297A SK 281857 B6 SK281857 B6 SK 281857B6
- Authority
- SK
- Slovakia
- Prior art keywords
- salts
- alkyl
- hydrogen
- halogen
- och
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH232394 | 1994-07-22 | ||
| PCT/EP1995/002841 WO1996003399A1 (de) | 1994-07-22 | 1995-07-19 | Dihydrobenzofurane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK297A3 SK297A3 (en) | 1997-08-06 |
| SK281857B6 true SK281857B6 (sk) | 2001-08-06 |
Family
ID=4231132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK2-97A SK281857B6 (sk) | 1994-07-22 | 1995-07-19 | Dihydrobenzofurány, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6121274A (fi) |
| EP (1) | EP0772610B9 (fi) |
| JP (1) | JP4146894B2 (fi) |
| KR (1) | KR100381584B1 (fi) |
| CN (1) | CN1068879C (fi) |
| AT (1) | ATE196765T1 (fi) |
| AU (1) | AU702346B2 (fi) |
| CZ (1) | CZ291758B6 (fi) |
| DE (1) | DE59508773D1 (fi) |
| DK (1) | DK0772610T3 (fi) |
| ES (1) | ES2152414T3 (fi) |
| FI (1) | FI970246A0 (fi) |
| GR (1) | GR3034991T3 (fi) |
| HU (1) | HU221504B (fi) |
| MX (1) | MX9700557A (fi) |
| NO (1) | NO311221B1 (fi) |
| NZ (1) | NZ290420A (fi) |
| PL (1) | PL185683B1 (fi) |
| PT (1) | PT772610E (fi) |
| RU (1) | RU2138498C1 (fi) |
| SK (1) | SK281857B6 (fi) |
| WO (1) | WO1996003399A1 (fi) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514996B2 (en) | 1995-05-19 | 2003-02-04 | Kyowa Hakko Kogyo Co., Ltd. | Derivatives of benzofuran or benzodioxole |
| AU705690B2 (en) * | 1995-05-19 | 1999-05-27 | Kyowa Hakko Kogyo Co. Ltd. | Oxygen-containing heterocyclic compounds |
| ATE215540T1 (de) * | 1995-12-05 | 2002-04-15 | Darwin Discovery Ltd | Benzofuran-carboxamide und -sulfonamide |
| PT912568E (pt) * | 1996-05-15 | 2003-04-30 | Altana Pharma Ag | Imidazopiridinas |
| RU2162467C2 (ru) * | 1996-05-20 | 2001-01-27 | Дарвин Дискавери Лимитед | Карбоксамиды бензофурана и их фармацевтическая композиция |
| DE19628621A1 (de) * | 1996-07-16 | 1998-01-22 | Byk Gulden Lomberg Chem Fab | Neue 4-substituierte Benzofurane |
| DE19628622A1 (de) * | 1996-07-16 | 1998-01-22 | Byk Gulden Lomberg Chem Fab | Neue 5-substituierte [2H] Chromene |
| DE69717827T2 (de) * | 1996-08-19 | 2003-09-04 | Altana Pharma Ag | Benzofuran-4-carboxamide |
| AU5652698A (en) * | 1996-11-12 | 1998-06-03 | Byk Gulden Lomberg Chemische Fabrik Gmbh | (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors |
| SI0941221T1 (en) * | 1996-11-20 | 2003-10-31 | Altana Pharma Ag | Substituted dihydrobenzofurans as pde inhibitors |
| US6380196B1 (en) | 1997-12-15 | 2002-04-30 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dihydrobenzofurans |
| GB2333041A (en) * | 1998-01-13 | 1999-07-14 | Johnson & Johnson Medical Ltd | Wound Composition |
| SI1075476T1 (en) | 1998-05-05 | 2003-10-31 | Altana Pharma Ag | Novel benzimidazoles and benzoxazoles |
| JP2002517495A (ja) * | 1998-06-10 | 2002-06-18 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | ホスホジエステラーゼ４の阻害剤としてのテトラヒドロフラニルオキシ置換基を有するベンズアミド |
| DE60043318D1 (de) | 1999-08-21 | 2010-01-14 | Nycomed Gmbh | Synergistische kombination von pumafentrine und salmeterol |
| GB0003257D0 (en) | 2000-02-11 | 2000-04-05 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
| EP1490048A4 (en) * | 2002-03-29 | 2005-06-01 | Chugai Pharmaceutical Co Ltd | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF RESPIRATORY DISEASES |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| KR20080053950A (ko) * | 2005-11-04 | 2008-06-16 | 닛뽕소다 가부시키가이샤 | 오르토 치환 아닐린 유도체 및 항산화약 |
| US7842713B2 (en) * | 2006-04-20 | 2010-11-30 | Pfizer Inc | Fused phenyl amido heterocyclic compounds |
| MY154498A (en) | 2007-05-16 | 2015-06-30 | Takeda Gmbh | Pyrazolone derivatives as pde4 inhibitors |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| MX354786B (es) | 2007-06-04 | 2018-03-21 | Synergy Pharmaceuticals Inc | Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos. |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| WO2010009319A2 (en) | 2008-07-16 | 2010-01-21 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| PE20110303A1 (es) | 2008-09-11 | 2011-05-21 | Pfizer | Derivados de heteroaril acetamidas como activadores de glucoquinasa |
| EP2406253B1 (en) | 2009-03-11 | 2013-07-03 | Pfizer Inc. | Benzofuranyl derivatives used as glucokinase inhibitors |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| US9580471B2 (en) | 2011-03-01 | 2017-02-28 | Synergy Pharmaceuticals, Inc. | Process of preparing guanylate cyclase C agonists |
| EP2803664B1 (en) * | 2012-01-12 | 2018-11-21 | Jiangsu Hengrui Medicine Co. Ltd. | Tetrahydrobenzofurane derivatives as gpr40 agonists for the treatment of diabetes |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法 |
| JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
| TWI713530B (zh) | 2015-06-05 | 2020-12-21 | 美商艾佛艾姆希公司 | 作為除草劑之嘧啶氧基苯衍生物 |
| WO2020237096A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Combination for lowering serum phosphate in a patient |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE71647B1 (en) * | 1991-01-28 | 1997-02-26 | Rhone Poulenc Rorer Ltd | Benzamide derivatives |
| WO1993025517A1 (en) * | 1992-06-15 | 1993-12-23 | Celltech Limited | Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| GB9212693D0 (en) * | 1992-06-15 | 1992-07-29 | Celltech Ltd | Chemical compounds |
-
1995
- 1995-07-19 AT AT95926953T patent/ATE196765T1/de not_active IP Right Cessation
- 1995-07-19 DK DK95926953T patent/DK0772610T3/da active
- 1995-07-19 ES ES95926953T patent/ES2152414T3/es not_active Expired - Lifetime
- 1995-07-19 KR KR1019970700420A patent/KR100381584B1/ko not_active IP Right Cessation
- 1995-07-19 US US08/750,920 patent/US6121274A/en not_active Expired - Lifetime
- 1995-07-19 RU RU97102828A patent/RU2138498C1/ru not_active IP Right Cessation
- 1995-07-19 HU HU9700022A patent/HU221504B/hu not_active IP Right Cessation
- 1995-07-19 DE DE59508773T patent/DE59508773D1/de not_active Expired - Lifetime
- 1995-07-19 CZ CZ1997188A patent/CZ291758B6/cs not_active IP Right Cessation
- 1995-07-19 CN CN95195177A patent/CN1068879C/zh not_active Expired - Fee Related
- 1995-07-19 EP EP95926953A patent/EP0772610B9/de not_active Expired - Lifetime
- 1995-07-19 PL PL95318297A patent/PL185683B1/pl not_active IP Right Cessation
- 1995-07-19 JP JP50543996A patent/JP4146894B2/ja not_active Expired - Lifetime
- 1995-07-19 WO PCT/EP1995/002841 patent/WO1996003399A1/de active IP Right Grant
- 1995-07-19 SK SK2-97A patent/SK281857B6/sk not_active IP Right Cessation
- 1995-07-19 NZ NZ290420A patent/NZ290420A/xx not_active IP Right Cessation
- 1995-07-19 AU AU31153/95A patent/AU702346B2/en not_active Ceased
- 1995-07-19 PT PT95926953T patent/PT772610E/pt unknown
- 1995-07-19 MX MX9700557A patent/MX9700557A/es not_active IP Right Cessation
-
1997
- 1997-01-09 NO NO19970092A patent/NO311221B1/no not_active IP Right Cessation
- 1997-01-21 FI FI970246A patent/FI970246A0/fi unknown
-
2000
- 2000-12-05 GR GR20000402680T patent/GR3034991T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2152414T3 (es) | 2001-02-01 |
| GR3034991T3 (en) | 2001-03-30 |
| WO1996003399A1 (de) | 1996-02-08 |
| SK297A3 (en) | 1997-08-06 |
| CZ291758B6 (cs) | 2003-05-14 |
| HU221504B (en) | 2002-10-28 |
| NO970092L (no) | 1997-01-09 |
| PT772610E (pt) | 2001-03-30 |
| NO311221B1 (no) | 2001-10-29 |
| US6121274A (en) | 2000-09-19 |
| NZ290420A (en) | 1999-01-28 |
| PL185683B1 (pl) | 2003-07-31 |
| CN1068879C (zh) | 2001-07-25 |
| JPH10503484A (ja) | 1998-03-31 |
| CN1159804A (zh) | 1997-09-17 |
| DK0772610T3 (da) | 2001-01-29 |
| EP0772610B1 (de) | 2000-10-04 |
| DE59508773D1 (de) | 2000-11-09 |
| ATE196765T1 (de) | 2000-10-15 |
| NO970092D0 (no) | 1997-01-09 |
| HUT77925A (hu) | 1998-11-30 |
| FI970246A (fi) | 1997-01-21 |
| PL318297A1 (en) | 1997-06-09 |
| KR100381584B1 (ko) | 2003-08-21 |
| FI970246A0 (fi) | 1997-01-21 |
| AU3115395A (en) | 1996-02-22 |
| HU9700022D0 (en) | 1997-02-28 |
| EP0772610A1 (de) | 1997-05-14 |
| EP0772610B9 (de) | 2001-07-25 |
| MX9700557A (es) | 1997-12-31 |
| CZ18897A3 (en) | 1997-09-17 |
| AU702346B2 (en) | 1999-02-18 |
| RU2138498C1 (ru) | 1999-09-27 |
| JP4146894B2 (ja) | 2008-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK281857B6 (sk) | Dihydrobenzofurány, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie | |
| US5712298A (en) | Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors | |
| EP0923568B9 (en) | Novel benzofuran-4-carboxamides | |
| JP4141501B2 (ja) | 新規の６位置換フェナントリジン | |
| US6080782A (en) | Cyclohexyl dihydrobenzofuranes | |
| JPH11505236A (ja) | フェニルジヒドロベンゾフラン | |
| AU757198B2 (en) | Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors | |
| CA2195663C (en) | Dihydrobenzofuranes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20100719 |